Global In-Vitro Fertilization (IVF) Market Growth (Status and Outlook) 2024-2030

According to our publisher latest study, the global In-Vitro Fertilization (IVF) market size was valued at US$ 14580 million in 2023. With growing demand in downstream market, the In-Vitro Fertilization (IVF) is forecast to a readjusted size of US$ 21920 million by 2030 with a CAGR of 6.0% during review period.

The research report highlights the growth potential of the global In-Vitro Fertilization (IVF) market. In-Vitro Fertilization (IVF) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of In-Vitro Fertilization (IVF). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the In-Vitro Fertilization (IVF) market.

In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a womans ovaries and fertilizing them with sperm outside the body, in vitro.

According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.

Key Features:

The report on In-Vitro Fertilization (IVF) market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the In-Vitro Fertilization (IVF) market. It may include historical data, market segmentation by Type (e.g., Culture Media, Disposable Devices), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the In-Vitro Fertilization (IVF) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Market Drivers:
Increasing Infertility Rates:
Rising infertility rates due to various factors such as lifestyle changes, stress, delayed pregnancies, and environmental influences are driving the demand for IVF treatments. Both male and female infertility issues are contributing to this trend.
Advancements in IVF Technology:
Technological advancements in assisted reproductive technologies (ART) such as improved embryo culture methods, preimplantation genetic testing, and cryopreservation techniques are enhancing the success rates of IVF treatments.
Growing Awareness and Acceptance:
Increased awareness about infertility treatments and growing societal acceptance of IVF are encouraging more couples to seek medical assistance for conception. Public awareness campaigns and educational programs are playing a significant role in reducing the stigma associated with IVF.
Favorable Government Initiatives and Funding:
Various governments are offering support through funding, subsidies, and favorable regulations to promote fertility treatments. Policies providing financial assistance and insurance coverage for IVF procedures are making these treatments more accessible.
Delayed Parenthood Trends:
The trend of delayed parenthood due to career aspirations, financial stability, and personal choices is leading to a higher demand for IVF treatments. Older age is associated with decreased fertility, prompting many couples to opt for assisted reproductive technologies.
Rising Disposable Income and Healthcare Expenditure:
Increasing disposable incomes and higher healthcare spending in both developed and emerging economies are enabling more couples to afford IVF treatments. This economic factor is contributing to the growth of the IVF market.
Challenges:
High Cost of IVF Procedures:
The high cost of IVF treatments, including multiple cycles that may be necessary for success, can be a significant barrier for many couples. The financial burden associated with IVF can deter potential patients from seeking treatment.
Ethical and Legal Issues:
Ethical concerns and legal issues surrounding IVF, such as the use of donor eggs and sperm, surrogacy, and embryo selection, pose challenges. Regulatory frameworks vary across countries, adding complexity to the IVF market.
Psychological and Emotional Impact:
The psychological and emotional stress associated with infertility and IVF treatments can be challenging for patients. The uncertainty of success and the physical and emotional toll of the procedures can affect mental health and well-being.
Limited Insurance Coverage:
In many regions, insurance coverage for IVF treatments is limited or nonexistent, making it difficult for couples to afford these procedures. The lack of comprehensive insurance support is a significant barrier to market growth.
Access and Availability:
Limited access to IVF clinics and specialized healthcare providers in certain regions, particularly in rural and underserved areas, restricts the availability of IVF treatments. Geographic disparities in access to fertility services are a notable challenge.
Variable Success Rates:
Success rates of IVF treatments can vary widely based on factors such as age, underlying medical conditions, and the specific techniques used. The variability in outcomes can affect patient confidence and market growth.
Trends:
Emergence of Advanced Diagnostic Techniques:
The use of advanced diagnostic techniques such as next-generation sequencing (NGS) for genetic screening and advanced imaging technologies is improving the accuracy of embryo selection and increasing IVF success rates.
Growth of Fertility Preservation:
Fertility preservation techniques, such as egg and sperm freezing, are becoming increasingly popular. These techniques allow individuals to preserve their fertility for future use, contributing to the growth of the IVF market.
Integration of AI and Machine Learning:
Artificial intelligence (AI) and machine learning are being integrated into IVF procedures to enhance decision-making, predict outcomes, and improve efficiency. AI-powered tools are helping in embryo selection and optimizing treatment protocols.
Rise of Personalized Medicine:
Personalized medicine approaches in IVF are gaining traction. Tailoring IVF treatments based on individual patient profiles, genetic information, and specific health conditions is leading to more effective and customized fertility solutions.
Telemedicine and Remote Monitoring:
The adoption of telemedicine and remote monitoring technologies in fertility treatments is increasing. Virtual consultations, remote monitoring of patients, and digital health platforms are enhancing patient access and convenience.
Focus on Male Infertility:
There is a growing focus on addressing male infertility issues, which account for a significant proportion of infertility cases. Advancements in male fertility treatments and diagnostics are expanding the scope of IVF services.
Competitive Landscape: The research report provides analysis of the competitive landscape within the In-Vitro Fertilization (IVF) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the In-Vitro Fertilization (IVF) industry. This include advancements in In-Vitro Fertilization (IVF) technology, In-Vitro Fertilization (IVF) new entrants, In-Vitro Fertilization (IVF) new investment, and other innovations that are shaping the future of In-Vitro Fertilization (IVF).
Technological Developments in the Global In-Vitro Fertilization (IVF) Market
Advanced Genetic Screening Techniques:
Preimplantation Genetic Testing (PGT): Before implantation, embryos can be screened for genetic abnormalities using techniques such as PGT-A (for aneuploidy), PGT-M (for monogenic diseases), and PGT-SR (for structural rearrangements). By choosing the healthiest embryos, these methods lower the danger of genetic abnormalities and increase the likelihood of a successful pregnancy.
Next-Generation Sequencing (NGS): NGS offers a comprehensive and high-resolution method for analyzing the genetic material of embryos, providing more accurate and detailed information compared to traditional methods. This technology improves the selection process and success rates of IVF cycles.
Cryopreservation Advances:
Vitrification: Vitrification is a rapid freezing technique that prevents the formation of ice crystals, which can damage cells during the freezing process. This method is now widely used for the cryopreservation of eggs, sperm, and embryos, leading to higher survival rates and better outcomes in IVF treatments.
Improved Storage Solutions: Developments in cryopreservation media and storage equipment have enhanced the long-term viability and safety of frozen gametes and embryos. These advancements ensure that biological materials maintain their integrity over extended periods.
AI and Machine Learning Integration:
Embryo Selection Algorithms: AI-powered algorithms are being developed to assist embryologists in selecting the most viable embryos for implantation. These algorithms analyze large datasets, including time-lapse images of embryo development, to predict the likelihood of successful implantation and pregnancy.
Predictive Analytics: Machine learning models are being used to predict patient outcomes based on individual profiles, treatment protocols, and historical data. These predictive tools help personalize treatment plans and improve overall success rates.
Enhanced Imaging and Monitoring:
Time-Lapse Imaging: Time-lapse imaging systems, such as the EmbryoScope, allow continuous monitoring of embryo development without disturbing the culture environment. These systems provide detailed insights into embryo morphology and development patterns, aiding in better selection decisions.
Non-Invasive Monitoring: Non-invasive techniques for monitoring embryo viability, such as metabolomic profiling of culture media, are being explored. These methods aim to assess embryo health without the need for invasive procedures, reducing potential risks.
Robotic and Automation Technologies:
Automated Sperm Selection: Robotic systems and microfluidic devices are being used to select the best-quality sperm for ICSI (intracytoplasmic sperm injection) procedures. These technologies improve the precision and efficiency of sperm selection, leading to higher fertilization rates.
Automated IVF Workstations: Automation in the IVF lab, including robotic handling of oocytes and embryos, enhances the consistency and accuracy of various processes. These systems reduce human error and improve overall laboratory efficiency.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the In-Vitro Fertilization (IVF) market. It includes factors influencing customer ' purchasing decisions, preferences for In-Vitro Fertilization (IVF) product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the In-Vitro Fertilization (IVF) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting In-Vitro Fertilization (IVF) market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the In-Vitro Fertilization (IVF) market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the In-Vitro Fertilization (IVF) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the In-Vitro Fertilization (IVF) market.
Recommendations:
Enhance Accessibility and Affordability:
Develop strategies to reduce the cost of IVF treatments and increase affordability. This could include offering financial assistance programs, advocating for insurance coverage, and exploring cost-effective treatment options.
Promote Public Awareness:
Increase public awareness and education about infertility and IVF treatments through targeted campaigns. Collaborate with healthcare providers, patient advocacy groups, and media to disseminate accurate information and reduce stigma.
Invest in Advanced Technologies:
Invest in the latest technologies and innovations in IVF to improve success rates and patient outcomes. Stay updated with advancements in genetic testing, AI, and personalized medicine to offer cutting-edge fertility solutions.
Expand Geographical Reach:
Expand the geographical reach of IVF services by establishing clinics in underserved and rural areas. Utilize telemedicine and remote consultation services to provide access to fertility treatments in remote regions.
Focus on Comprehensive Care:
Provide comprehensive care that addresses the physical, emotional, and psychological aspects of infertility. Offer counseling, support groups, and holistic treatment plans to support patients throughout their IVF journey.
Opportunities:
Emerging Markets:
Explore opportunities in emerging markets where rising disposable incomes and increasing awareness of fertility treatments are driving demand. Tailor marketing strategies and services to meet the needs of these markets.
Fertility Preservation Services:
Expand fertility preservation services, including egg and sperm freezing, to cater to individuals seeking to delay parenthood. This growing segment offers significant growth potential for IVF clinics and providers.
Collaborations and Partnerships:
Form strategic collaborations and partnerships with research institutions, healthcare providers, and technology companies. These alliances can drive innovation, enhance service offerings, and improve patient outcomes.
Patient-centric Approaches:
Adopt patient-centric approaches that prioritize patient experience and satisfaction. Implement personalized treatment plans, provide clear communication, and offer flexible scheduling to enhance patient care.
Regulatory Advocacy:
Engage in regulatory advocacy to influence policies that support IVF treatments. Work with industry associations and stakeholders to advocate for favorable regulations, insurance coverage, and funding support.
Market Segmentation:

In-Vitro Fertilization (IVF) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

Culture Media

Disposable Devices

Capital Equipment

Segmentation by application

Fertility Clinics

Hospitals

Surgical Centers

Clinical Research Institutes

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

OvaScience

EMD Serono Inc.

Vitrolife AB

Irvine Scientific

Cook Medical Inc.

Cooper Surgical Inc.

Genea Biomedx

Thermo Fisher Scientific Inc.

Progyny Inc.

Boston IVF

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Ask an Expert

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now